NorthWest Biotherapeutics Inc (NWBO)

[beartrap12]

Alexander, Linda Powers has several times said at shareholders’ meetings I attended that if she got an offer she couldn’t refuse, she’d take it. When Dave threw out those comparative numbers, I would guess he’s talking about actually comparing what those companies had to offer and what they were bought out for to what we have to offer. And with top line, we have a lot more to offer. We all know that our technology is transferable to any solid tumor. NWBO already has the Ph I and II clinical studies in ovarian cancer that show similar efficacy to what we’re seeing in GBM. And they’ve evidently done a lot of compassionate care with DCVaxL in colon cancer in Israel, when they had a clinical setup there. (The last according to a statement Linda made a few years ago.) Knowing this, I think you would have to extrapolate those numbers Dave threw out to include some value for the other solid cancers we know DCVax will work with in order to satisfy Linda. And then, of course, there’s Direct.
So, yes, I can see Dave Innes stating that Linda will sell the company after top line data if she gets her price, but I suspect her price is much higher than the what Juno or Kite sold for, and probably, in my opinion, higher than those two combined. After all, remember, those two vied for the same space.